title: Corrigendum: Selective inhibition of EZH2 by ZLD1039 blocks H3K27methylation and leads to potent anti-tumor activity in breast cancer.
authors.forename: Xuejiao
authors.initials: X
authors.lastname: Song
authors.forename: Tiantao
authors.initials: T
authors.lastname: Gao
authors.forename: Ningyu
authors.initials: N
authors.lastname: Wang
authors.forename: Qiang
authors.initials: Q
authors.lastname: Feng
authors.forename: Xinyu
authors.initials: X
authors.lastname: You
authors.forename: Tinghong
authors.initials: T
authors.lastname: Ye
authors.forename: Qian
authors.initials: Q
authors.lastname: Lei
authors.forename: Yongxia
authors.initials: Y
authors.lastname: Zhu
authors.forename: Menghua
authors.initials: M
authors.lastname: Xiong
authors.forename: Yong
authors.initials: Y
authors.lastname: Xia
authors.forename: Fangfang
authors.initials: F
authors.lastname: Yang
authors.forename: Yaojie
authors.initials: Y
authors.lastname: Shi
authors.forename: Yuquan
authors.initials: Y
authors.lastname: Wei
authors.forename: Lidan
authors.initials: L
authors.lastname: Zhang
authors.forename: Luoting
authors.initials: L
authors.lastname: Yu